Oncology Institute (TOIIW) Total Non-Current Liabilities (2020 - 2026)

Oncology Institute (TOIIW) has reported Total Non-Current Liabilities for 7 consecutive years, with $184.5 million the latest figure, recorded in Q1 2026.

• Total Non-Current Liabilities for Q1 2026 came in at $184.5 million, up 16.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $184.5 million (up 16.17% YoY), and the FY2025 annual result was $180.3 million, up 6.88% from the prior year.
• Total Non-Current Liabilities was $184.5 million for Q1 2026 at Oncology Institute, up from $180.3 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $184.5 million in Q1 2026 and troughed at $62.6 million in Q2 2022.
• Average Total Non-Current Liabilities over 5 years is $145.9 million, with a median of $151.8 million recorded in 2023.
• Year-over-year, Total Non-Current Liabilities surged 646.25% in 2022 and decreased 2.54% in 2025.
• Over 5 years, Total Non-Current Liabilities stood at $134.5 million in 2022, then gained by 12.87% to $151.8 million in 2023, then advanced by 11.12% to $168.7 million in 2024, then gained by 6.88% to $180.3 million in 2025, then gained by 2.3% to $184.5 million in 2026.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $184.5 million in Q1 2026, $180.3 million in Q4 2025, and $162.2 million in Q3 2025.